Scarica l'app Stockscreener
681.72
1.06%
7.17
Pre-mercato:
686.09
4.37
+0.64%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Precedente Chiudi:
$674.55
Aprire:
$678.89
Volume 24 ore:
1.21M
Relative Volume:
1.17
Capitalizzazione di mercato:
$71.01B
Reddito:
$14.25B
Utile/perdita netta:
$4.58B
Rapporto P/E:
16.32
EPS:
41.7701
Flusso di cassa netto:
$3.88B
1 W Prestazione:
+5.83%
1M Prestazione:
+20.74%
6M Prestazione:
+18.43%
1 anno Prestazione:
-16.96%
Intervallo 1D:
$672.67
$690.78
Intervallo di 1 settimana:
$640.83
$690.78
Portata 52W:
$476.49
$823.56
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
Nome
Regeneron Pharmaceuticals Inc
Settore
Industria
Telefono
(914) 847-7000
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Confronta REGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-14 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-30 | Downgrade | Argus | Buy → Hold |
| 2025-05-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-02-05 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | Iniziato | Bernstein | Outperform |
| 2024-01-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | Reiterato | Oppenheimer | Perform |
| 2023-06-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-23 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2023-01-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-09-09 | Aggiornamento | Jefferies | Underperform → Hold |
| 2022-09-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | Iniziato | Cantor Fitzgerald | Neutral |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-01-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-01-03 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-12-07 | Ripresa | Cowen | Market Perform |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Ripresa | BMO Capital Markets | Outperform |
| 2021-11-05 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-06-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-01-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-01-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-10-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-09 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-05-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-17 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-04-08 | Iniziato | The Benchmark Company | Hold |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-02-26 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-11 | Aggiornamento | Argus | Hold → Buy |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-16 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-12-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | Iniziato | SunTrust | Hold |
| 2019-11-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-09-23 | Aggiornamento | Guggenheim | Neutral → Buy |
Mostra tutto
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
How Regeneron Pharmaceuticals Inc. (RGO) stock responds to job market shiftsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Regeneron plans $2 billion investment at Saratoga Springs facility - The Business Journals
Palouse Capital Management Inc. Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Simplify Asset Management Inc. Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Illinois Municipal Retirement Fund Acquires 1,851 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
ProShare Advisors LLC Purchases 6,051 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
AGF Management Ltd. Sells 798 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Can a trend reversal in Regeneron Pharmaceuticals Inc. lead to recoveryJuly 2025 Retail & Daily Chart Pattern Signals - newser.com
Regeneron Pharmaceuticals (NASDAQ:REGN) VP Jason Pitofsky Sells 431 Shares - MarketBeat
Tangible book value per share of Regeneron Pharmaceuticals, Inc. – DUS:RGO - TradingView
What does recent volatility data suggest for Regeneron Pharmaceuticals Inc.July 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial - Benzinga
Profund Advisors LLC Buys 1,388 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
News impact scoring models applied to Regeneron Pharmaceuticals Inc.July 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by Fagan Associates Inc. - MarketBeat
Factory Mutual Insurance Co. Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ellerson Group Inc. ADV Trims Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks - The Globe and Mail
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology PipelineSlideshow (NASDAQ:REGN) 2025-11-10 - Seeking Alpha
Regeneron Executive Cashes In on Stock Sale! - TipRanks
Regeneron VP controller Pitofsky sells $280k in stock - Investing.com
VP Pitofsky Sells 431 ($280.8K) Of Regeneron Pharmaceuticals Inc [REGN] - TradingView
Merck showcases data suggesting PCSK9 pill might rival cholesterol-lowering shots - BioPharma Dive
Transcript : Regeneron Pharmaceuticals, Inc.Special Call - MarketScreener
How strong is Regeneron Pharmaceuticals Inc. stock balance sheet2025 Macro Impact & Daily Volume Surge Signals - newser.com
How robust is Regeneron Pharmaceuticals Inc. (RGO) stock financial positionQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Alvotech Wins Legal Battle In The UK High Court For AVT06, A Eylea Biosimilar - Nasdaq
Prospera Financial Services Acquires Regeneron Shares Amid Nasdaq Composite - Kalkine Media
Mitsubishi UFJ Asset Management Co. Ltd. Has $109.76 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Prospera Financial Services Inc Buys 10,320 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
RWA Wealth Partners LLC Lowers Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
How Regeneron Pharmaceuticals Inc. stock responds to policy changes2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Metis Global Partners LLC Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by Aviva PLC - MarketBeat
Can Regeneron Pharmaceuticals Inc. stock weather global recessionWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
UK court rejects Regeneron’s injunction against Alvotech’s Eylea biosimilar By Investing.com - Investing.com Canada
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept) - The Manila Times
UK court rejects Regeneron’s injunction against Alvotech’s Eylea biosimilar - Investing.com
What data driven models say about Regeneron Pharmaceuticals Inc.’s futureWeekly Trade Review & High Win Rate Trade Alerts - newser.com
Looking Into Regeneron Pharmaceuticals Inc's Recent Short Interest - Sahm
Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendationsJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
Is Regeneron Pharmaceuticals Inc. trending in predictive chart modelsWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Regeneron Pharmaceuticals' (NASDAQ:REGN) Anemic Earnings Might Be Worse Than You Think - simplywall.st
Modera Wealth Management LLC Reduces Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Andra AP fonden Has $1.58 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Acadian Asset Management LLC Increases Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
How Positive Phase 2 Results for Novel Antibodies at Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story - Yahoo Finance
How Merck Is Taking On Amgen, Regeneron In Cholesterol - Investor's Business Daily
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $660.00 Price Target at UBS Group - MarketBeat
Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):